Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP880794.RAV1nbtU-n4r5nmq9ZAAdF7jC-R_1xmydqdfgCqD0dId4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP880794.RAV1nbtU-n4r5nmq9ZAAdF7jC-R_1xmydqdfgCqD0dId4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP880794.RAV1nbtU-n4r5nmq9ZAAdF7jC-R_1xmydqdfgCqD0dId4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP880794.RAV1nbtU-n4r5nmq9ZAAdF7jC-R_1xmydqdfgCqD0dId4130_provenance.
- NP880794.RAV1nbtU-n4r5nmq9ZAAdF7jC-R_1xmydqdfgCqD0dId4130_assertion wasGeneratedBy ECO_0000203 NP880794.RAV1nbtU-n4r5nmq9ZAAdF7jC-R_1xmydqdfgCqD0dId4130_provenance.
- NP880794.RAV1nbtU-n4r5nmq9ZAAdF7jC-R_1xmydqdfgCqD0dId4130_assertion wasDerivedFrom befree-20140225 NP880794.RAV1nbtU-n4r5nmq9ZAAdF7jC-R_1xmydqdfgCqD0dId4130_provenance.
- NP880794.RAV1nbtU-n4r5nmq9ZAAdF7jC-R_1xmydqdfgCqD0dId4130_assertion SIO_000772 19553641 NP880794.RAV1nbtU-n4r5nmq9ZAAdF7jC-R_1xmydqdfgCqD0dId4130_provenance.
- NP880794.RAV1nbtU-n4r5nmq9ZAAdF7jC-R_1xmydqdfgCqD0dId4130_assertion evidence source_evidence_literature NP880794.RAV1nbtU-n4r5nmq9ZAAdF7jC-R_1xmydqdfgCqD0dId4130_provenance.
- NP880794.RAV1nbtU-n4r5nmq9ZAAdF7jC-R_1xmydqdfgCqD0dId4130_assertion description "[Olaparib has few of the adverse effects of conventional chemotherapy, inhibits PARP, and has antitumor activity in cancer associated with the BRCA1 or BRCA2 mutation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP880794.RAV1nbtU-n4r5nmq9ZAAdF7jC-R_1xmydqdfgCqD0dId4130_provenance.
- befree-20140225 importedOn "2014-02-25" NP880794.RAV1nbtU-n4r5nmq9ZAAdF7jC-R_1xmydqdfgCqD0dId4130_provenance.